$4.14
0.215.34%
Last update: Oct 28, 5:20 PM
Biodexa Pharmaceuticals PLC (BDRX) Stock Price, Quote, News & History
BDRXNASDAQ
Enovix jumps 6.8% after securing a 100,000-unit battery order from a multinational drone maker, with deliveries planned for H1 2027.
You can purchase shares of Biodexa Pharmaceuticals (NASDAQ:BDRX) through any online brokerage.
Other companies in Biodexa Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Biodexa Pharmaceuticals has a consensus price target of $80000.00.
The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $3.94 last updated October 28, 2026 at 5:20 PM EDT.
There are no upcoming dividends for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder...
